AbbVie is a global, research-based biopharmaceutical company. AbbVie's mission is to provide innovative medicines for some of the world’s most complex and serious diseases, and to address the medical challenges of tomorrow. AbbVie aims to have a remarkable impact on people's lives through the work we do in a range of therapeutic areas: immunology, oncology, neuroscience, eye care and virology, and in medical aesthetics with the Allergan Aesthetics portfolio.

https://www.abbvie.com/

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Please visit astrazeneca.com and follow the Company on social media @AstraZeneca.

BeiGene is a global biotechnology company that is discovering and developing innovative oncology treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them.

https://www.beigene.com/

Janssen is one of the world's leading research-based pharmaceutical companies and part of the global healthcare company Johnson & Johnson. Our goal is to build a world where complex diseases are prevented, treated or cured, where treatments are smarter and solutions are personal. In Oncology, Janssen focuses on innovative medicines for hematological diseases like CLL and multiple myeloma, and solid tumors like prostate, bladder, and lung cancer.

www.janssen.com/germany

Lilly verbindet Fürsorge mit Forschergeist, um Medikamente zu entwickeln, die das Leben von Menschen verbessern. Seit fast 150 Jahren leisten wir Pionierarbeit und erzielen wissenschaftliche Durchbrüche in Bereichen wie Diabetes, Adipositas, Alzheimer-Demenz, Autoimmunerkrankungen und Krebs. Heute helfen unsere Medikamente mehr als 49 Millionen Menschen auf der ganzen Welt. 

Wenn Sie mehr über Lilly erfahren wollen, besuchen Sie uns auf www.lilly.com/de oder www.linkedin.com/showcase/lilly-deutschland 

Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials, and cancer medicines.

roche.com 

More information will follow in due course.

Prelude’s approach is to apply its expertise in cancer biology and medicinal chemistry to identify targetable intervention points in cancer signaling pathways. Once a target is identified, Prelude employs its internal discovery engine to design and synthesize novel inhibitors or degraders. Our pipeline consists of highly differentiated molecules that were optimized to block key oncogenic pathways in hematological malignancies and solid tumors.

https://preludetx.com/